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CVP = central venous pressure; LV = left ventricular; PAC = pulmonary artery catheter; PCO2 = partial carbon dioxide tension; Ppao = pulmonary
arterial occlusion pressure; RV = right ventricular; ScvO2 = central venous oxygen saturation; SvO2 = mixed venous oxygen saturation.
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Abstract
Hemodynamic monitoring is a central component of intensive care.
Patterns of hemodynamic variables often suggest cardiogenic,
hypovolemic, obstructive, or distributive (septic) etiologies to
cardiovascular insufficiency, thus defining the specific treatments
required. Monitoring increases in invasiveness, as required, as the
risk for cardiovascular instability-induced morbidity increases
because of the need to define more accurately the diagnosis and
monitor the response to therapy. Monitoring is also context
specific: requirements during cardiac surgery will be different from
those in the intensive care unit or emergency department. Solitary
hemodynamic values are useful as threshold monitors (e.g.
hypotension is always pathological, central venous pressure is only
elevated in disease). Some hemodynamic values can only be
interpreted relative to metabolic demand, whereas others have
multiple meanings. Functional hemodynamic monitoring implies a
therapeutic application, independent of diagnosis such as a
therapeutic trial of fluid challenge to assess preload
responsiveness. Newer methods for assessing preload
responsiveness include monitoring changes in central venous
pressure during spontaneous inspiration, and variations in arterial
pulse pressure, systolic pressure, and aortic flow variation in
response to vena caval collapse during positive pressure
ventilation or passive leg raising. Defining preload responsiveness
using these functional measures, coupled to treatment protocols,
can improve outcome from critical illness. Potentially, as these and
newer, less invasive hemodynamic measures are validated, they
could be incorporated into such protocolized care in a cost-
effective manner.
Introduction
Hemodynamic monitoring is a cornerstone of care for the
hemodynamically unstable patient, but it requires a manifold
approach and its use is both context and disease specific.
One of the primary goals of hemodynamic monitoring is to
alert the health care team to impending cardiovascular crisis
before organ injury ensues; it is routinely used in this manner
in the operating room during high-risk surgery. Another goal
of hemodynamic monitoring is to obtain information specific
to the disease processes, which may facilitate diagnosis and
treatment and allow one to monitor the response to therapy.
The effectiveness of hemodynamic monitoring depends both
on available technology and on our ability to diagnose and
effectively treat the disease processes for which it is used.
The utility of hemodynamic monitoring has evolved as it has
merged with information technology and as our understanding
of disease pathophysiology has improved. Within this context,
hemodynamic monitoring represents a functional tool that may
be used to derive estimates of performance and physiological
reserve that may in turn direct treatment. However, no
monitoring device can improve patient-centered outcomes
useless it is coupled to a treatment that improves outcome.
Thus, hemodynamic monitoring must be considered within the
context of proven medical therapies, success of which is
dependent on the clinical condition, pathophysiological state
and ability to reverse the identified disease process.
Rationale for hemodynamic monitoring
A progression of arguments supporting the use of specific
monitoring techniques can be proposed. At the basic level,
monitoring can be defended on the basis of historical
controls. In this regard, prior experience with similar
monitoring techniques indicates that they can identify known
complications that are undetectable with less invasive means.
Clearly, the mechanism by which the benefit is achieved need
not be understood or even postulated.
Further support for hemodynamic monitoring comes from an
understanding of the pathophysiology of the process being
treated, such as heart failure or hypovolemic shock. Weil and
Shubin [1] defined circulatory shock as decreased ability of
blood flow to meet the metabolic demands of the body. Using
their classic approach, four basic groups of circulatory shock
can be defined: hypovolemic, cardiogenic, obstructive, and
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distributive. Certain combinations of hemodynamic findings
allow the etiology of circulatory shock to be defined using this
nosology. Tissue hypoperfusion is common in all forms of
shock (with the possible exception of hyperdynamic septic
shock). Because specific types of circulatory shock require
different therapies and target end-points of resuscitation,
defining the cardiovascular state is important in determining
both treatment options and their goals. Much of the rationale
for hemodynamic monitoring resides at this level. The implied
assumption here is that knowledge of how a disease process
creates its effect will allow one to prevent the process from
altering measured bodily functions, thus preventing disease
progression and promoting recovery. This argument may not
be valid, primarily because knowledge of the specific process
in individual patients is often inadequate. Furthermore,
measures of global blood flow and systemic arterial pressure,
and changes in them in response to shock and its treatment
poorly reflect regional and microcirculatory blood flow [2-4].
The most important support for hemodynamic monitoring is
that, by altering therapy in otherwise unexpected ways, it can
improve outcome in terms of survival and quality of life. Few
therapies can claim such a benefit, although the trial by
Rivers and coworkers [5] represents a notable exception in
this regard; those investigators reported that measures of
blood flow sufficiency and resuscitation to sustain blood flow
improved outcome from septic shock.
Hemodynamic monitoring must also be considered within the
context of the patient, pathophysiology, time point in the
disease process, and position within the health care delivery
system at which it is used. The site where monitoring takes
place has a major impact on type of monitoring, and its risks,
utility and efficacy. Monitoring outside the hospital and
emergency department may be less invasive than in the
operating room or intensive care unit. The time point during
the course of disease when monitoring is applied will also
have profound effects on outcome. For example, preoperative
optimization of cardiovascular status [6] and emergency
department early goal-directed therapy in septic shock [5]
reduces morbidity, whereas the same monitoring and
treatment applied after injury in unstable patients with existing
shock-induced organ injury does not improve outcome [7-9].
Static hemodynamic monitoring variables
Specific hemodynamic variables are commonly measured and
displayed at the bedside, and their values are often used in
clinical decision making. However, the utility of each variable
as a single absolute value is questionable. Some individual
hemodynamic values are useful primarily as threshold
monitors. For example, because a primary determinate of
organ perfusion is perfusion pressure, systemic hypotension
to below a certain threshold is clinically relevant. Furthermore,
elevation in central venous pressure (CVP; i.e. >10 mmHg)
reflects right ventricular (RV) pressure overload, although this
gives no information on the precise etiology involved. Other
hemodynamic values can only be interpreted relative to
metabolic demand. For example, because blood flow varies to
match metabolic requirements, which in turn can vary
considerably, there is no one specific value of cardiac output
or oxygen delivery that can be defined as ‘normal’. These
characteristics of blood flow reflect either an ability or an
inability to meet the metabolic demands of the body. Finally,
other measures are of questionable value in evaluating one
parameter but are important in monitoring another. For
example, pulmonary arterial occlusion pressure (Ppao) is a
poor measure of left ventricular (LV) preload but is a good
measure of the back-pressure to pulmonary blood flow and
the hydrostatic forces producing pulmonary edema.
Some specific uses for hemodynamic values measured at a
single point in time are described in Table 1. Although
grouping hemodynamic variables in order to define profiles
can improve diagnostic accuracy, there are few reports of
improved outcomes resulting from such refinements in data
analysis. Nevertheless, in the following discussion we
consider the primary hemodynamic measures that are
commonly used in critically ill patients.
Blood pressure
Arterial blood pressure is not a single pressure but a range of
pressure values from systole and diastole. Mean arterial
pressure best approximates the organ perfusion pressure in
noncardiac tissues, as long as venous or surrounding
pressures are not elevated. Arterial pressure is commonly
measured noninvasively on an intermittent basis using a
sphygmomanometer [10]. Indwelling arterial catheters permit
continuous monitoring of arterial pressure. Because blood
pressure is a regulated variable, a normal blood pressure
does not necessarily reflect hemodynamic stability [11].
Organ systems also tend to autoregulate their blood flow
such that organ-specific blood flow remains constant within a
wide range of blood pressures if metabolic rate is
unchanged, and varies with changes in local metabolic rate.
The lower limit of this flow autoregulation, based on mean
arterial pressure, varies between organs, patients (based on
their underlying circulatory status, for example essential
hypertension or peripheral vascular disease), their disease
state, their metabolic activity, and associated vasoactive
therapies.
Thus, there is no threshold blood pressure value that defines
adequate organ perfusion among organs, between patients,
or in the same patient over time [12]. However, because
arterial pressure is a primary determinant of organ blood flow,
hypotension (mean arterial pressure <65 mmHg) is always
pathological.
Central venous pressure
CVP is the back-pressure to systemic venous return.
Because CVP is usually very low, defining the appropriate
hydrostatic zero level is important in estimating CVP, but568
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such physiological zeroing can be difficult. Few absolutes can
be stated regarding static measures of CVP. If CVP is
10 mmHg or less then cardiac output will uniformly decrease
when 10 cmH2O positive end-expiratory pressure is given to
ventilator-dependent patients [13], whereas a CVP above
10 mmHg has no predictive value. Demonstration, using
echocardiographic techniques, of more than 36% superior
vena caval collapse during positive-pressure inspiration [14]
or complete inferior vena caval collapse [15,16] identifies
individuals whose CVP is below 10 mmHg. However, there is
no threshold value of CVP that identifies patients whose
cardiac output will increase in response to fluid resuscitation
[17]. Importantly, CVP is only elevated in disease, but the
clinical utility of CVP as a guide to diagnosis or therapy has
not been demonstrated.
Pulmonary artery catheter
The pulmonary artery catheter (PAC) permits LV filling
pressures to be estimated by measuring Ppao [18,19].
However, Ppao values do not correlate with LV end-diastolic
volume, and neither do they predict preload responsiveness
[20]. Nevertheless, Ppao is the back-pressure to pulmonary
blood flow, and it can be used to identify the presence of a
hydrostatic component to pulmonary edema and to assess
pulmonary vascular resistance. Using a rapid response
thermistor, the PAC can be used to monitor RV end-diastolic
volume based on measures of residual thermal signal.
Measures of changes in RV end-diastolic volume are useful in
cardiac surgery when trying to identify right-sided cardiac
failure. If RV end-diastolic volume increases as cardiac output
decreases, then the patient has cor pulmonale [21]. Using a
transthoracic measure of thermal decay, one can estimate
intrathoracic blood volume, global cardiac volume, and lung
water. Of these three measures, intrathoracic blood volume is
presently the most widely used technique, although
intrathoracic lung water measures may be of interest in the
management of patients with acute lung injury. Intrathoracic
blood volume and its changes in response to fluid challenge
reflect LV preload and changes in LV preload better than do
more conventional measures, such as CVP or Ppao [17,22].
However, the utility of any of these measures as static single-
point values in predicting preload responsiveness or in
improving outcome in unstable patients has not been
documented.
Indicator dilution techniques using thermal, indocyanine
green, and lithium can measure blood flow from both central
venous and PAC [23]. LV stroke volume can be estimated
using a beat-to-beat based, algorithmic analysis of arterial
pulse pressure [24]. Several monitoring techniques use
subtle variations in this concept to calculate stroke volume
and cardiac output. The overall accuracy of these techniques
varies. Esophageal Doppler techniques can be used to
measure descending aortic flow [25-27] and to estimate both
stroke volume and cardiac output. Because accurate
measurement of cardiac output is less important than
accurate documentation of trends in flow, these measures
may have profound clinical utility if they are accurate and
stable over time.
Recall that there is no normal cardiac output; because
cardiac output varies with metabolic demand, it is either able
Table 1
Clinical caveats for hemodynamic variables
Type of 
hemodynamic 
variable Parameter Comments
Solitary  Blood pressure Hypotension is always pathological
Central venous pressure (CVP) CVP is only elevated in disease
Pulmonary artery occlusion pressure (Ppao) Ppao is the back-pressure to pulmonary blood flow
Cardiac output There is no normal cardiac output, only an adequate or inadequate one
Mixed venous oxygen saturation (SvO2) Decreasing SvO2 is a sensitive but nonspecific marker of cardiovascular 
stress
Dynamic Volume challenge Positive response defined as an increase in any of blood pressure, CVP, 
Ppao, cardiac output and/or SvO2, or a decrease in heart rate
Echocardiographic analysis of vena cavae  Complete inferior vena caval collapsea
collapse during positive pressure inspiration 
identifies CVP <10 mmHg if it detects >36% collapse in superior vena cavaa
Defining preload responsiveness ≥13% pulse pressure variation during positive pressure ventilationa
>1 mmHg decrease in CVP during spontaneous inspirationb
aRequires a fixed tidal volume of 6–8 ml/kg and complete adaptation to the ventilator. bRequires a spontaneous inspiratory effort greater than
–2 mmHg to be valid.569
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or unable to meet these demands. Measures of mixed venous
oxygen saturation (SvO2) may reflect better the adequacy of
oxygen delivery. The normal value for SvO2 is 75–70%.
Exercise, anemia, hypoxemia, and decreased cardiac output
all independently decrease SvO2. Although SvO2 above 70%
does not necessarily reflect adequate tissue oxygenation, a
persistently low SvO2 (>30%) is associated with tissue
ischemia [28]. Measures of central venous oxygen saturation
(ScvO2) tend to track SvO2. However, ScvO2 and SvO2 are
not equal, and so use of ScvO2 to define thresholds of
resuscitation requires one to give special attention to related
clinical variables [29]. Splanchnic oxygen consumption can
be estimated from hepatic venous oxygen saturation and
hepatic venous blood flow measures [30]. However, this
measure has not been shown to be superior to less invasive
techniques in directing resuscitation or in improving outcome.
Hypoperfusion initially decreases blood flow but not oxidative
phosphorylation; thus, tissue partial carbon dioxide tension
(PCO2) reflects both local metabolism and regional blood
flow. If blood flow decreases then tissue PCO2 will increase
relative to arterial PCO2. Measurement of this PCO2 gap could
allow one to assess whether tissue blood flow is effective.
Measures of gastric [31] and sublingual [32,33] PCO2 gaps
identify tissue hypoperfusion. Gastric tonometry is useful in
guiding resuscitation in critically ill patients [31], and
sublingual PCO2 measures may have similar utility.
Functional hemodynamic monitoring:
defining response to therapy
Although one may use hemodynamic monitoring to identify
cardiovascular insufficiency before it results in clinical
hypoperfusion or as a prognostic indicator of survival, its
greatest potential role is in directing application of cardio-
vascular therapies that are of proven efficacy. Monitoring
conducted to evaluated the effect of treatment can be
referred to as functional monitoring, because it implies a
therapeutic application. Although trends in specific variables
over time are useful in defining hemodynamic stability, their
rapid change in response to application of a therapy has
greater clinical utility. Some examples of functional monitoring
variables are given in Table 1. The most common example of
functional monitoring is in a therapeutic trial. Below we list
the various types of functional monitoring presently validated.
Volume challenge
The time-honored method of assessing preload responsive-
ness is to administer a relatively small intravascular volume
bolus rapidly and observe the subsequent hemodynamic
response in terms of blood pressure, pulse, cardiac output,
SvO2 and related measures. There is little agreement
regarding what absolute volume and infusion rate defines an
adequate fluid challenge. In a volume challenge trial estimates
of improved circulatory status (e.g. increasing blood pressure
and decreasing heart rate) and improved effective blood flow
(e.g. increasing SvO2 and decreasing blood lactate) are used
to document a beneficial response. The primary factor
addressed by a fluid challenge is preload responsiveness;
specifically, will cardiac output increase with fluid loading?
Importantly, being preload responsive does not equate to
requiring fluid resuscitation. Normal individuals are preload
responsive but do not require resuscitation. Thus, a fluid
challenge must be conducted within the context of known or
suspected tissue hypoperfusion [34]. Furthermore, a volume
challenge is not fluid resuscitation; it is merely a test to
identify those who are preload responsive [35]. Volume
responders can then be given additional fluid resuscitation
with minimal risk for worsening cor pulmonale or inducing
pulmonary edema.
However, a volume change, as a primary diagnostic approach
in hemodynamically unstable patients, has important clinical
drawbacks. First, only half of all hemodynamically unstable
patients are preload responsive [36]. Second, it delays
primary therapy in a setting where delayed appropriate
treatment has consequences for survival. Finally, a volume
challenge in an unresponsive patient may worsen or
precipitate pulmonary edema or cor pulmonale. Therefore,
several surrogate methods of creating reversible or transient
volume challenges, including breathing and passive leg
raising, have been advocated.
Passive leg raising
Passive leg raising to 30° transiently increases venous return
[37] in patients who are preload responsive. Leg raising only
transiently increases cardiac output in responders, and so it
is not a treatment for hypovolemia. When coupled with
measures of aortic flow, patients exhibiting a sustained (15 s)
increase in mean aortic flow 30 s after leg raising were found
to be preload responsive [38]. The advantages of this
approach are that it is easy perform, induces only a transient
and reversible volume challenge, yields volume challenges
proportional to individual body size, and can be repeated as
needed to reassess preload responsiveness. Limitations of
the technique are that, presently, only measures of mean
aortic flow, using esophageal Doppler, can assess preload
responsiveness and that the blood volume mobilized by leg
raising is dependent on total blood volume and so could be
small in severely hypovolemic patients [39].
Changes in central venous pressure during
spontaneous breathing
With spontaneous inspiration, venous return normally
increases in association with the decrease in intrathoracic
pressure [40]. If the right ventricle can transfer this transient
bolus of blood into the pulmonary circulation, then CVP will
correlate with intrathoracic pressure, decreasing with each
spontaneous inspiratory effort. An inspiratory decrease in
CVP of more than 1 mmHg in the setting of an intrathoracic
pressure decrease of more than 2 mmHg accurately predicts
preload responsiveness, whereas those patients whose CVP
does not decrease do not increase their cardiac output in570
response to fluid challenge [41]. This simple approach
requires central venous catheterization, and one must give
close attention to CVP waveform analysis. During positive
pressure ventilation, the interpretation of CVP as reflected by
changes in inferior vena cava diameter is complex and of
minimal diagnostic utility.
Changes in left ventricular output during positive
pressure ventilation
If changes in both right and left ventricles induce changes in
output, then one can use positive pressure ventilation to
assess the dynamic and necessarily cyclic effect of ventilation
on venous return by assessing dynamic swings in LV output.
The greater the increase in tidal volume for the same lung
compliance, the greater is the transient decrease in venous
return and subsequently greater decrease in LV output [42].
Changes in systolic arterial pressure during a programmed
series of increasing tidal breaths quantify the degree of
preload responsiveness [43]. Furthermore, during fixed tidal
volume positive pressure ventilation, variations in systolic
pressure [44], pulse pressure [45], LV stroke volume [46],
and aortic flow [47] are robust measures of preload
responsiveness. Michard and coworkers [45] found that a
systolic pressure or a pulse pressure variation of 13% or
more in septic patients breathing with a tidal volume of
8 ml/kg is highly sensitive and specific for preload
responsiveness. In contrast, no threshold values for either
Ppao or CVP could be identified that were better than
random chance in predicting preload responsiveness.
One can estimate LV stroke volume based on the arterial
pressure pulse contour. Several studies conducted in
patients undergoing surgery have documented a good
relation between this measure of pulse contour derived stroke
volume variation and preload responsiveness [48].
Unfortunately, the accuracy of the pulse contour algorithm
used to calculate stroke volume is proprietary and has
changed on commercially available devices since these
validation studies were preformed [49]. Thus, the extent to
which these measures accurately track real stroke volume
fluctuations is unclear. Furthermore, because these various
devices calculate stoke volume differently, the threshold
values for each parameter in predicting preload responsive-
ness may be different between devices, and may exhibit
different degrees of robustness under varying clinical
conditions. Changes in vasomotor tone [50] will also alter the
observed changes in each parameter and may do so to
proportionally different degrees. Thus, more clinical validation
work must be done on these measures before they may
become standard measures in most intensive care units.
Standardization of care
The application of evidence-based guidelines to clinical
practice is rational. This approach often reduces health care
costs by reducing practice variations, medical errors, and
length of stay [51]. Fluid optimization as an end-point of
resuscitation reduces length of hospital stay and important
complications in patients undergoing a variety of major
surgical procedures that routinely require postoperative
resuscitation, but the degree of this effect varies among
patients [52-54]. Cost-effectiveness analyses of specific
types of treatment directed by hemodynamic monitoring,
namely SvO2 monitoring to identify adequacy of treatment for
hemodynamic instability [55] and preoptimization in high-risk
surgery patients [56], have demonstrated benefit. These
studies underscore the importance of examining the utility of
monitoring systems within the context of a specific disease
process coupled to effective treatment protocols.
Conclusion
Fundamentally, one may ask just three questions regarding
the cardiovascular system during resuscitation from shock
[57]: will blood flow to the body increase with fluid
resuscitation?; is arterial hypotension due to inadequate
blood flow or loss of vasomotor tone, or both?; and is the
heart capable of maintaining effective blood flow without
going into failure? If the answer to the first question is ‘yes’,
then treatment must include volume expansion. However, if
the patient is also hypotensive and has reduced vasomotor
tone, then vasopressor therapy may be started simultaneously
because arterial pressure will not increase with volume
expansion alone, even though cardiac output will increase. If
the patient is not preload responsive but has reduced vaso-
motor tone associated with hypotension, then a vasopressor
alone is indicated. If the patient is neither preload responsive
nor exhibiting reduced vasomotor tone and hypotension, then
the problem is the heart, and both diagnostic and therapeutic
actions must be taken to address these specific problems
(e.g. echocardiography, dobutamine). Protocolized cardio-
vascular management based on functional hemodynamic
monitoring has the added advantages of being intuitively
obvious (facilitating buy-in by stakeholders), pleuripotential
(many different monitoring devices can all drive the same
protocol) and scalable (alter intensity of resuscitation), and
lends itself to automation.
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